Life Science in Germany
JLL and KGAL examine the market for office and laboratory buildings – users have to dig deepest into their pockets in Berlin, while the most space is let in Munich
Investments in life science real estate have so far played a subordinate role at best among institutional investors – at least in Germany. This is likely to change in the coming years. Driven by the success of companies such as Biontech, research and laboratory facilities as well as associated office buildings are increasingly becoming the focus of national and international investors. As a result, rents and capital values are expected to rise, because the sector is focusing on high-quality space and is also prepared to pay the necessary rents for it. This is the conclusion reached by JLL and KGAL in their joint study "Life Science in Germany".
Table of Contents:
- The importance of the life science segment in Germany
- Location and site requirements of users
- Life science real estate - characterisation, demarcation and user requirements
- Lease characteristics in the life science segment
- Life science rental market and rents in the most important clusters
- Investment market and yields of life science properties